ATE529119T1 - Physiologisch wirksame zusammensetzung und verfahren zu ihrer herstellung - Google Patents

Physiologisch wirksame zusammensetzung und verfahren zu ihrer herstellung

Info

Publication number
ATE529119T1
ATE529119T1 AT05710527T AT05710527T ATE529119T1 AT E529119 T1 ATE529119 T1 AT E529119T1 AT 05710527 T AT05710527 T AT 05710527T AT 05710527 T AT05710527 T AT 05710527T AT E529119 T1 ATE529119 T1 AT E529119T1
Authority
AT
Austria
Prior art keywords
basidiomycetes
fungus belonging
belonging
producing
extract component
Prior art date
Application number
AT05710527T
Other languages
English (en)
Inventor
Tadashi Goino
Original Assignee
Tadashi Goino
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tadashi Goino filed Critical Tadashi Goino
Application granted granted Critical
Publication of ATE529119T1 publication Critical patent/ATE529119T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/074—Ganoderma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Botany (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
AT05710527T 2004-02-16 2005-02-16 Physiologisch wirksame zusammensetzung und verfahren zu ihrer herstellung ATE529119T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004038443 2004-02-16
PCT/JP2005/002824 WO2005077395A1 (ja) 2004-02-16 2005-02-16 生理活性組成物及びその製造方法

Publications (1)

Publication Number Publication Date
ATE529119T1 true ATE529119T1 (de) 2011-11-15

Family

ID=34857807

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05710527T ATE529119T1 (de) 2004-02-16 2005-02-16 Physiologisch wirksame zusammensetzung und verfahren zu ihrer herstellung

Country Status (8)

Country Link
US (1) US20070178118A1 (de)
EP (1) EP1736206B1 (de)
JP (1) JPWO2005077395A1 (de)
CN (1) CN1921871A (de)
AT (1) ATE529119T1 (de)
DK (1) DK1736206T3 (de)
ES (1) ES2372696T3 (de)
WO (1) WO2005077395A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO20014256D0 (no) * 2001-09-03 2001-09-03 Bjoern Kristiansen Fremstilling av immunstimulerende forbindelse
US7514085B2 (en) * 2004-07-16 2009-04-07 Medimush A/S Immune modulating compounds from fungi
CN101396424B (zh) * 2008-07-30 2010-12-22 刘超 一种治疗和预防心脑血管疾病的药物组合物及其制备方法
EP2468253A1 (de) 2010-12-14 2012-06-27 InterMed Discovery GmbH Terpenoidspiroketalverbindungen mit LXR-Agonistenaktivität, deren Verwendung und Formulierungen damit
CN102397302A (zh) * 2011-11-18 2012-04-04 四川省南充绿宝菌业科技有限公司 天然桑黄与原木赤灵芝活性物质提取物的生产方法及产品
CN113616737A (zh) * 2021-07-29 2021-11-09 山东臻稀生物科技有限公司 一种抗肿瘤且低毒无副作用的稀土多菌糖中药组方

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466455A (en) * 1990-10-18 1995-11-14 Huffstutler, Jr.; Miles C. Polyphase fluid-extraction process, resulting products and methods of use
RU2129003C1 (ru) * 1998-04-10 1999-04-20 Гоино Тадаши Средство, обладающее противоопухолевой активностью
JP2000143526A (ja) * 1998-11-13 2000-05-23 Asuke Yakuhin Kk 田七人参、霊芝、アガリクス茸を主成分とする糖尿・高血圧・肝機能改善剤およびこれの製造方法
CN1195534C (zh) * 2000-01-31 2005-04-06 五井野正 担子菌亚门和五加科提取物的生理活性组合物
JP2002000229A (ja) * 2000-06-23 2002-01-08 S F C:Kk 健康食品
WO2002038166A2 (en) * 2000-11-07 2002-05-16 University Of Chicago Ginseng berry extracts and pharmaceutical compositions therefrom
JP2002235084A (ja) * 2001-02-08 2002-08-23 Ishikawa Tennen Yakko Busshitsu Kenkyu Center 抗酸化剤
JP2002315570A (ja) * 2001-04-24 2002-10-29 Yukito Akiyama ＳＯＤ様物質を生産するＰｈｅｌｌｉｎｕｓｌｉｎｔｅｕｓの培養方法及びＳＯＤ様物質の製造方法
JP2002363092A (ja) * 2001-06-01 2002-12-18 Tadashi Goino 抗高脂血症組成物及びその製造方法
JP3619189B2 (ja) * 2001-12-26 2005-02-09 チハヤ株式会社 食品組成物及び食品組成物の製造方法
AU2003202159A1 (en) * 2002-04-08 2003-10-27 Ginseng Science Inc. Extract of processed panax genus plant, the preparation method thereof, and compositions containing the same
US7977379B2 (en) * 2002-05-15 2011-07-12 Bhn Co., Ltd. Method for angiogenesis inhibition or immunostimulation
JP4369096B2 (ja) * 2002-05-29 2009-11-18 正 五井野 賦形剤組成物

Also Published As

Publication number Publication date
EP1736206B1 (de) 2011-10-19
ES2372696T3 (es) 2012-01-25
EP1736206A4 (de) 2009-07-29
WO2005077395A1 (ja) 2005-08-25
EP1736206A1 (de) 2006-12-27
US20070178118A1 (en) 2007-08-02
CN1921871A (zh) 2007-02-28
DK1736206T3 (da) 2012-01-16
JPWO2005077395A1 (ja) 2007-10-18

Similar Documents

Publication Publication Date Title
ATE529119T1 (de) Physiologisch wirksame zusammensetzung und verfahren zu ihrer herstellung
Chang Global impact of edible and medicinal mushrooms on human welfare in the 21st century: nongreen revolution
Flores Arzú et al. A preliminary checklist of macrofungi of Guatemala, with notes on edibility and traditional knowledge
Karunarathna et al. Three new species of Lentinus from northern Thailand
WO2002020727A3 (en) Method for propagating fungi using solid state fermentation
WO2011094579A3 (en) Mushroom compositions and methods for making and using
WO2008097482A3 (en) Mycellated grain and other myceliated agricultural materials to be used as animal food supplement
Ogidi et al. Wild medicinal mushrooms: potential applications in phytomedicine and functional foods
Üstün Makrofungusların besin değeri ve biyolojik etkileri
Zhao et al. Optimization of process parameters of the Pholiota squarrosa extracellular polysaccharide by Box–Behnken statistical design
Van Griensven Culinary-medicinal mushrooms: Must action be taken?
Tian et al. A phylogenetic assessment of Pholiota and the new genus Pyrrhulomyces
YR Mushroom diversity of Dhenkanal District, Odisha, India: source of alternative foods and medicines
Sysouphanthong et al. A review of genus Lepiota and its distribution in east Asia
Kim et al. Phylogenetic analysis of Antrodia and related taxa based on partial mitochondrial SSU rDNA sequences
Bolaniran et al. An appraisal of the metabolites, pharmacological and biotechnological significance of edible mushrooms
Chang The need for scientific validation of culinary-medicinal mushroom products
PE20060157A1 (es) Composicion natural que comprende extracto de monascus fungus y uva
Kengni Ayissi et al. Some noteworthy taxonomic variations in the complex wood-decayer Ganoderma resinaceum (Basidiomycota) with reference to collections from tropical Africa
CN104221703A (zh) 牛樟芝菌体培养方法及培养基底成份
ATE395410T1 (de) Basidiomyzeten, basidiomyzetenextraktzusammensetzung sowie reformkost und immunopotentiatoren
Kaya et al. Determination of total phenolic content, antioxidant activity and eritadenine compound of wild mushrooms in Kayseri region and cultivated medicinal mushrooms.
GAFUR et al. Plant tolerance as a component of Ganoderma philippii management in Acacia mangium plantations
RU2358782C2 (ru) Способ немедикаментозного снижения гиперхолестеринемии
Haimed et al. Inventory of Basidiomycetes and Ascomycetes Harvested in the Moroccan Central Plateau

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties